How do you start a hospice care agency business in 2027?

A Referral Call That Exposes Every Gap in the Plan

Picture a hospital discharge planner calling a brand-new hospice agency on a Friday afternoon about a 78-year-old CHF patient whose family wants care to start that weekend. This single call is the stress test every hospice startup eventually fails or passes, and it reveals exactly which pieces of the business had to be built before day one. Can the agency accept the referral without a Medicare provider number yet active? No — without CMS certification, the visit happens, but nothing is billable, so the founder either eats the cost or turns the family away, and turning a family away at a moment like this destroys the referral relationship permanently. Is there a hospice medical director on record who can co-certify the six-month terminal prognosis alongside the attending physician? If that role is still an unsigned offer letter, the admission stalls. Does the agency have a 24/7 on-call RN roster, a pharmacy relationship that can deliver a comfort kit (opioid, anti-nausea, anti-anxiety, secretion-management medications) to the home within hours, and a DME vendor who can drop off a hospital bed and oxygen concentrator before Monday? Every one of those has to exist operationally before the first patient is accepted, not after.

This scenario is why the licensing sequence matters as much as the capital. A founder who raises $300,000 but starts recruiting the interdisciplinary team only after the state license arrives will lose the first six months of referral credibility to competitors who showed up staffed and ready. Discharge planners, oncology nurses, and skilled nursing facility social workers — the people who actually generate 60–75% of admissions — remember which agency answered the phone on a weekend and which one apologized and called back Monday. A new hospice business earns its way onto a hospital's short list of trusted providers one weekend admission at a time, and losing that first test case can set a launch back by a full referral cycle (30–90 days) while the discharge planner quietly reroutes future patients elsewhere.

The founders who navigate this well typically run a "soft staffing" phase during the 12–24 month licensing window: they hire the Director of Patient Care Services and medical director early, sign pharmacy and DME contracts before the state survey, and use that lag time to build relationships with hospital case managers and SNF administrators so that the moment the Medicare provider number activates, the referral pipeline isn't starting from zero. Waiting until certification lands to start relationship-building is the single most common reason a technically licensed hospice sits at a 10-15 patient census for its first year instead of ramping toward the 50-100 average daily census that makes the business durable.

How the Licensing and Certification Mechanism Actually Works

Getting a hospice agency from concept to a billing Medicare provider runs through a specific sequence, and understanding the order — not just the checklist — prevents the most expensive mistake: doing steps out of order and having to redo them. First comes business formation and, in 17 states (including New York, Georgia, Tennessee, Virginia, and Connecticut), a Certificate of Need application, which can take 6–18 months on its own and is rejected in roughly half of submissions due to demonstrated market saturation. States without CON move straight to state Department of Health hospice licensure, which requires a completed business plan, proof of an RN as clinical director, an operations manual, and typically $2,000–$12,000 in filing fees.

Once the state license is granted, the agency files CMS Form 855A for Medicare provider enrollment. This does not itself trigger certification — it queues the agency for an initial survey, either conducted directly by the state DOH on CMS's behalf or satisfied through deemed-status accreditation by CHAP, ACHC, or The Joint Commission, each of which runs its own on-site survey against the 42 CFR 418 Conditions of Participation (patient rights, initial and comprehensive assessment, the interdisciplinary group requirement, quality assessment and performance improvement, core services, volunteer hours at 5% of patient care hours). Only after that survey passes does CMS issue an active Medicare provider number, and the agency must admit its first patient within six months of approval or risk losing the certification.

The practical trap in this sequence is hiring the clinical director and medical director too late, because the state license application and the CMS-855A both require those names on file before either agency will move the file forward. A founder who waits to make those hires until after the license is "almost approved" adds months to the timeline. The efficient path staffs the two required clinical leadership roles immediately after entity formation, runs the state license and CMS-855A applications in parallel rather than sequentially, and uses accreditation (rather than waiting on a state-survey queue that can run 3-6 months behind in busy states) to compress the certification timeline.

Real Numbers: What This Business Actually Costs and Earns

The capital picture depends heavily on which of three entry paths a founder chooses, and conflating them is the most common budgeting error. Starting a de novo hospice agency in a non-CON state runs $185,000–$485,000 in startup capital, covering office lease ($24,000–$85,000 annually for 2,500–5,000 square feet), state and CMS filing fees ($5,000–$25,000), initial accreditation ($15,000–$45,000), an electronic medical record system ($25,000–$85,000 setup plus $1,000–$3,000 monthly), 6–12 months of payroll runway for the core interdisciplinary team ($85,000–$285,000), first-year insurance ($25,000–$95,000 combining professional liability, workers' compensation, and auto coverage), and legal and consulting fees ($25,000–$85,000). Starting de novo in one of the 17 CON states pushes that to $485,000–$1.5 million once CON application and consulting fees, competing-application legal costs, and the extended review timeline are added — which is why many founders targeting a CON state instead acquire an existing licensed hospice (a change-of-ownership transaction) for $1.5 million–$8 million, priced at roughly 0.8–1.5 times annual revenue or 6–10 times EBITDA depending on average daily census and survey history.

On the revenue side, hospice is a per-diem business under the Medicare Hospice Benefit: Routine Home Care pays roughly $215 per patient per day (the dominant rate, covering about 98% of all hospice days regardless of how many visits happen that day), while Continuous Home Care (~$1,710/day), Inpatient Respite Care (~$510/day), and General Inpatient Care (~$1,180/day) cover acute or crisis scenarios and together make up the remaining 2% of days. A mature 100-average-daily-census hospice — meaning roughly 100 patients under care on any given day — generates $8 million to $12 million in annual revenue with 12–22% EBITDA margins, which is notably healthier than comparable home-health or skilled-nursing businesses because the per-diem structure pays a stable rate regardless of daily service intensity, once the interdisciplinary team is fully loaded.

Staffing eats 40–55% of that revenue. A 100-ADC hospice typically runs 35–55 total staff: 7–10 RN case managers at a 1:12–1:15 patient ratio ($80,000–$120,000 each), 2–4 triage/on-call RNs, a contracted medical director at 0.2–1.0 FTE ($185,000–$385,000 annualized), 2–3 medical social workers, 1–2 chaplains, 8–15 hospice aides, and a volunteer coordinator managing the federally required 5% volunteer-hour minimum. RN turnover running 35–55% industry-wide is the single largest threat to that margin, since contract agency RNs bill at $85–$135 per hour against a $80,000–$120,000 core salary — a 2.5–3x premium that can quietly erase a quarter's profitability if agency reliance climbs above 10-15% of nursing hours.

Trade-Offs: Build From Scratch vs. Acquire vs. Joint Venture

The founder's biggest strategic decision isn't the business plan — it's which of three structurally different entry paths to take, and each trades speed, capital, and control differently. Building de novo gives full control over culture, hiring, and IDT design, and it's the cheapest path in non-CON states, but it means absorbing 12–24 months of pre-revenue burn while competing against established agencies for the same referral sources with zero track record. Acquiring an existing operating hospice (a change-of-ownership transaction) buys an active Medicare provider number, an existing census, accreditation already in hand, and — critically — established referral relationships that would otherwise take years to build; the trade-off is 4–8x the capital outlay and inheriting whatever compliance history, audit exposure, or clinical culture problems the prior owner leaves behind. A hospital or health-system joint venture trades away majority control and slows decision-making but removes most of the capital risk and instantly supplies referral volume from the partner's own discharge pipeline — often the fastest route to a sustainable census, though it caps the founder's long-term equity upside.

A related trade-off sits inside the operating model once the agency is running: whether to build a general inpatient (GIP) unit for acute symptom management or rely on contracted GIP beds at a partner hospital or skilled nursing facility. A freestanding inpatient unit costs $3 million–$15 million and only makes sense above roughly 500 average daily census; nearly every startup and mid-size hospice instead contracts GIP beds, trading a smaller per-day margin (the hospital partner typically keeps $400–$650 of the ~$1,180 GIP per-diem) for avoiding a real-estate commitment entirely. This is the same build-versus-partner calculus that shows up in adjacent care models — home health agencies, palliative care programs, even the revenue-cycle discipline a RevOps team applies when deciding whether to build billing infrastructure in-house or route it through a specialized partner: the capital-light path almost always wins until volume is large enough to justify owning the infrastructure outright.

Common Pitfalls in the First 24 Months

The costliest mistake is treating length-of-stay growth as pure upside without watching the Medicare Cap — an aggregate annual limit of roughly $35,000 per patient that, when exceeded, must be repaid to CMS. Agencies that admit a heavy mix of dementia and adult-failure-to-thrive patients (whose prognosis under the FAST 7C staging tool is clinically ambiguous and can run 12–24+ months) without monitoring cap exposure in real time can find themselves owing six figures back to Medicare at year-end reconciliation. The fix is building cap-monitoring into the EMR or a dedicated tool from day one, not adding it after the first cap overage notice arrives.

A second pitfall is under-investing in referral-source infrastructure relative to clinical infrastructure. Founders correctly focus early capital on licensing, staffing, and accreditation, but 60–75% of admissions flow through only 5–15 key referral relationships — hospital discharge planners, SNF social workers, oncology nurses — and an agency that doesn't dedicate a community liaison role to those relationships from the first month of operation will find its census stalling well below break-even even after certification is complete. Losing even one or two major referral sources can collapse census within 30–60 days, so referral diversification across at least eight to ten sources should be a deliberate early-stage target, not something addressed reactively.

Third, missing the administrative claim deadlines — the Notice of Election within 5 days of admission and the face-to-face recertification encounter within 30 days of each benefit-period renewal — triggers automatic payment denials regardless of how appropriate the clinical care was. New agencies without a dedicated hospice biller who understands sequential billing discipline routinely lose revenue to missed deadlines in their first six months, which is why the billing/business-office hire should happen alongside the clinical hires, not after the first billing cycle reveals the gap. Finally, under-budgeting insurance is common: a 100-ADC hospice's full first-year insurance load (professional liability, general liability, workers' compensation, cyber, auto, umbrella) typically runs $150,000–$650,000, and founders who budget only for the cheapest professional-liability quote get blindsided by workers' compensation costs once real payroll — classified under the home-health/hospice NCCI code — starts flowing.

Related questions

How long does it take to get Medicare hospice certification?

Typically 12–24 months for a de novo agency in a non-CON state, covering state licensing, CMS-855A enrollment, staffing, and the initial certification survey. CON-state entry or change-of-ownership acquisitions run on different timelines — 6–18 months for CON review, or 60–180 days for an acquisition's provider-number transfer.

What's the difference between hospice and palliative care as a business model?

Palliative care isn't necessarily terminal and bills under Medicare Part B physician and facility fees; hospice requires a six-month terminal prognosis and is reimbursed through Medicare's four per-diem levels regardless of daily service intensity. Many operators run palliative care as an upstream referral pipeline into their hospice business.

How much does hospice accreditation cost?

CHAP, ACHC, or Joint Commission accreditation typically runs $8,000–$35,000 for the initial application and survey, plus $5,000–$15,000 annually, with a full on-site resurvey roughly every three years.

Can you start a hospice agency without an RN on staff?

No. Federal Conditions of Participation under 42 CFR 418 require a Director of Patient Care Services who is a registered nurse, plus RN case managers meeting a roughly 1:12–1:15 patient ratio — this is a non-negotiable staffing requirement before certification is granted.

FAQ

Is a hospice agency profitable in the first year? Almost never. Most de novo agencies operate at a loss through the 12–24 month licensing and census-ramp period, since revenue only begins after Medicare certification and census typically takes 12–18 months to reach a stabilizing 50+ average daily census.

What's the minimum average daily census to break even? Most operators target somewhere between 40 and 60 average daily census to cover the fixed cost of the required interdisciplinary team, though the exact break-even point depends heavily on local payer mix, real estate costs, and how much GIP or contracted inpatient capacity the agency carries.

Do you need a physician owner to start a hospice business? No, but you do need a contracted or employed hospice medical director — typically 0.2–1.0 FTE — who co-certifies terminal prognoses alongside the attending physician. Many successful founders are nurses, administrators, or business operators who hire the medical director rather than serving in that role themselves.

How is a hospice agency different from a home health agency for licensing purposes? Home health agencies serve non-terminal patients on an intermittent, visit-based Medicare reimbursement model (PDGM) and require homebound status; hospice serves terminally ill patients under a flat per-diem model and requires the specific interdisciplinary team and volunteer-hour infrastructure defined in 42 CFR 418. The licensing pathways (state DOH, CMS enrollment, accreditation) are similar in structure but governed by different Conditions of Participation.

What happens if a hospice exceeds the Medicare Cap? The agency must repay the excess amount to CMS during the annual cap reconciliation process. This is why cap monitoring — tracking aggregate per-patient Medicare payments against the roughly $35,000 annual limit — needs to be built into daily operations rather than checked only at year-end.

Is a Certificate of Need required in every state? No — as of the mid-2020s roughly 17 states still require CON for hospice, including New York, Georgia, Tennessee, and Virginia; the remaining states allow direct state DOH licensure without a separate need-based approval process.

Sources

• https://www.cms.gov/medicare/coverage/hospice
• https://www.cms.gov/regulations-and-guidance/guidance/manuals/downloads/bp102c09.pdf
• https://www.nhpco.org
• https://www.chapinc.org
• https://www.achc.org
• https://www.jointcommission.org
• https://www.medpac.gov
• https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-B/part-418
• https://www.ncsl.org/health/certificate-of-need-state-laws

Related on PULSE

• How do you start a home health care agency business?
• What is the Medicare Hospice Benefit and how does per-diem reimbursement work?
• How do you build a referral pipeline for a healthcare services business?
• What are the Conditions of Participation for Medicare-certified providers?
• How does a business choose between organic growth and acquisition to enter a regulated industry?
• What does RevOps discipline look like in a healthcare services business?